Shares of Ensign Group (ENSG) jumped 7.43% in after-hours trading on Thursday following the company's strong second-quarter earnings report and increased full-year guidance. The healthcare services provider posted better-than-expected results and raised its outlook, citing continued operational momentum across its portfolio.

For Q2 2025, Ensign reported adjusted earnings per share of $1.59, surpassing the analyst consensus estimate of $1.55. Revenue came in at $1.23 billion, also beating expectations of $1.22 billion. The company saw notable improvements in key metrics, with same-facility skilled mix increasing to 32.4% from 30.9% in the prior year quarter, and occupancy rising to 82.1% from 80.5%.

Based on the strong first half performance, Ensign raised its 2025 earnings guidance to between $6.34 and $6.46 per diluted share, up from the previous range of $6.22 to $6.38. The company also increased its annual revenue forecast to $4.99 billion to $5.02 billion, up from $4.89 billion to $4.94 billion previously. Management expressed confidence in capturing further growth opportunities, citing the significant organic potential in its existing portfolio and the successful integration of recently acquired operations.